CRDF logo

Cardiff Oncology (CRDF) Long Term Liabilities

Annual Total Long Term Liabilities

$1.46 M
-$582.00 K-28.53%

31 December 2023

CRDF Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$979.00 K
-$162.00 K-14.20%

30 September 2024

CRDF Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRDF Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.5%-39.1%
3 y3 years+224.0%-64.1%
5 y5 years+25.1%-10.7%

CRDF Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-43.2%+224.0%-64.1%at low
5 y5 years-43.2%+224.0%-64.1%+313.1%
alltimeall time-91.1%+224.0%-95.2%+313.1%

Cardiff Oncology Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$979.00 K(-14.2%)
June 2024
-
$1.14 M(-12.3%)
Mar 2024
-
$1.30 M(-10.8%)
Dec 2023
$1.46 M(-28.5%)
$1.46 M(-9.3%)
Sept 2023
-
$1.61 M(-8.3%)
June 2023
-
$1.75 M(-7.6%)
Mar 2023
-
$1.90 M(-7.0%)
Dec 2022
$2.04 M(-20.6%)
$2.04 M(-6.2%)
Sept 2022
-
$2.17 M(-5.7%)
June 2022
-
$2.31 M(-5.4%)
Mar 2022
-
$2.44 M(-5.1%)
Dec 2021
$2.57 M(+470.7%)
$2.57 M(-5.8%)
Sept 2021
-
$2.73 M(+1050.2%)
June 2021
-
$237.00 K(-14.4%)
Mar 2021
-
$277.00 K(-38.4%)
Dec 2020
$450.00 K(-54.7%)
$450.00 K(-7.4%)
Sept 2020
-
$485.80 K(-37.9%)
June 2020
-
$782.90 K(-1.0%)
Mar 2020
-
$790.70 K(-20.4%)
Dec 2019
$993.50 K(-14.7%)
$993.50 K(-9.3%)
Sept 2019
-
$1.10 M(-17.3%)
June 2019
-
$1.33 M(-15.1%)
Mar 2019
-
$1.56 M(+34.1%)
Dec 2018
$1.17 M
$1.17 M(-8.6%)
Sept 2018
-
$1.27 M(+18.8%)
June 2018
-
$1.07 M(-42.8%)
DateAnnualQuarterly
Mar 2018
-
$1.88 M(+2.3%)
Dec 2017
$1.83 M(-88.8%)
$1.83 M(-42.6%)
Sept 2017
-
$3.19 M(+101.0%)
June 2017
-
$1.59 M(-88.9%)
Mar 2017
-
$14.29 M(-12.8%)
Dec 2016
$16.39 M(+12.7%)
$16.39 M(-16.7%)
Sept 2016
-
$19.66 M(+48.3%)
June 2016
-
$13.26 M(-10.0%)
Mar 2016
-
$14.73 M(+1.3%)
Dec 2015
$14.54 M(-9.4%)
$14.54 M(-4.3%)
Sept 2015
-
$15.20 M(-26.1%)
June 2015
-
$20.57 M(+21.3%)
Mar 2015
-
$16.96 M(+5.6%)
Dec 2014
$16.06 M(+237.7%)
$16.06 M(-7.1%)
Sept 2014
-
$17.29 M(+2.4%)
June 2014
-
$16.88 M(+261.3%)
Mar 2014
-
$4.67 M(-1.7%)
Dec 2013
$4.75 M(-45.8%)
$4.75 M(-28.5%)
Sept 2013
-
$6.65 M(-37.4%)
June 2013
-
$10.63 M(+42.0%)
Mar 2013
-
$7.49 M(-14.6%)
Dec 2012
$8.77 M(+128.2%)
$8.77 M(+208.9%)
Sept 2012
-
$2.84 M(-12.0%)
June 2012
-
$3.23 M(-19.0%)
Mar 2012
-
$3.98 M(+3.7%)
Dec 2011
$3.84 M(+84.1%)
$3.84 M
Dec 2010
$2.09 M
-

FAQ

  • What is Cardiff Oncology annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Cardiff Oncology?
  • What is Cardiff Oncology annual total long term liabilities year-on-year change?
  • What is Cardiff Oncology quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Cardiff Oncology?
  • What is Cardiff Oncology quarterly long term liabilities year-on-year change?

What is Cardiff Oncology annual total long term liabilities?

The current annual total long term liabilities of CRDF is $1.46 M

What is the all time high annual total long term liabilities for Cardiff Oncology?

Cardiff Oncology all-time high annual total long term liabilities is $16.39 M

What is Cardiff Oncology annual total long term liabilities year-on-year change?

Over the past year, CRDF annual total long term liabilities has changed by -$582.00 K (-28.53%)

What is Cardiff Oncology quarterly total long term liabilities?

The current quarterly long term liabilities of CRDF is $979.00 K

What is the all time high quarterly long term liabilities for Cardiff Oncology?

Cardiff Oncology all-time high quarterly total long term liabilities is $20.57 M

What is Cardiff Oncology quarterly long term liabilities year-on-year change?

Over the past year, CRDF quarterly total long term liabilities has changed by -$628.00 K (-39.08%)